Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00053196
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+3 more
Alliance for Clinical Trials in Oncology 82
Large-scale testing (Phase 3)UnknownNCT06116734
What this trial is testing

Lapelga vs Gastrofil

Who this might be right for
Multiple MyelomaLymphomaEngagement, Patient+1 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 74
Not applicableUnknownNCT02300571
What this trial is testing

Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Hematological Malignancies
Fondazione del Piemonte per l'Oncologia 60
Not applicableUnknownNCT06491719
What this trial is testing

A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT

Who this might be right for
CAEBV (Chronic Active Epstein-Barr Virus Infection) SyndromeEBVHemophagocytic Lymphohistiocytoses
Beijing Friendship Hospital 15
Large-scale testing (Phase 3)Active Not RecruitingNCT02443077
What this trial is testing

Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell TypeRefractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI) 94
Large-scale testing (Phase 3)Study completedNCT00016081
What this trial is testing

Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation

Who this might be right for
Infection
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00006350
What this trial is testing

Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT01477606
What this trial is testing

Protocol in Acute Myeloid Leukemia With FLT3-ITD

Who this might be right for
Acute Myeloid Leukemia
University of Ulm 451
Testing effectiveness (Phase 2)Study completedNCT05311514
What this trial is testing

Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease

Who this might be right for
Ocular Graft-versus-host Disease
St. Petersburg State Pavlov Medical University 38
Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Ended earlyNCT02681302
What this trial is testing

Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence

Who this might be right for
Multiple MyelomaLymphoma
Hackensack Meridian Health 46
Early research (Phase 1)Study completedNCT00301730
What this trial is testing

Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung

Who this might be right for
Breast CancerMetastatic Cancer
National Cancer Institute (NCI) 1
Early research (Phase 1)Ended earlyNCT00674427
What this trial is testing

Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
University of Pennsylvania 13
Testing effectiveness (Phase 2)Study completedNCT03436862
What this trial is testing

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

Who this might be right for
Hodgkin Lymphoma
SCRI Development Innovations, LLC 37
Large-scale testing (Phase 3)Study completedNCT00070187
What this trial is testing

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 24
Not applicableUnknownNCT05532826
What this trial is testing

Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT

Who this might be right for
Chronic Active Epstein-Barr Virus InfectionVirus-Associated Hemophagocytic Syndrome
Beijing Friendship Hospital 15
Early research (Phase 1)Ended earlyNCT04328714
What this trial is testing

Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Edwin Horwitz 4
Testing effectiveness (Phase 2)Study completedNCT00526292
What this trial is testing

Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04564703
What this trial is testing

Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

Who this might be right for
Multiple Myeloma
Stichting European Myeloma Network 160
Next Page